lorazepam has been researched along with mivacurium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Doenicke, A; Lorenz, W; Mayer, M; Nebauer, AE; Peter, K; Rosenberger, C | 1 |
1 review(s) available for lorazepam and mivacurium
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for lorazepam and mivacurium
| Article | Year |
|---|---|
[Pharmacodynamics and clinical adverse effects of mivacurium. The effect of oral premedication with H1/H2 antagonists].
Topics: Administration, Oral; Adolescent; Adult; Anti-Anxiety Agents; Benzodiazepines; Dimethindene; Double-Blind Method; Female; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Isoquinolines; Lorazepam; Male; Middle Aged; Mivacurium; Neuromuscular Nondepolarizing Agents; Preanesthetic Medication; Ranitidine | 1993 |
1 other study(ies) available for lorazepam and mivacurium
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |